<SEC-DOCUMENT>0001193125-13-451324.txt : 20131122
<SEC-HEADER>0001193125-13-451324.hdr.sgml : 20131122
<ACCEPTANCE-DATETIME>20131122160553
ACCESSION NUMBER:		0001193125-13-451324
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20131118
ITEM INFORMATION:		Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20131122
DATE AS OF CHANGE:		20131122

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ORTHOFIX INTERNATIONAL N V
		CENTRAL INDEX KEY:			0000884624
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				000000000
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-19961
		FILM NUMBER:		131238307

	BUSINESS ADDRESS:	
		STREET 1:		7 ABRAHAM DE VEERSTRAAT
		STREET 2:		CURACAO
		CITY:			NETHERLANDS ANTILLES
		STATE:			P8
		ZIP:			00000
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d633841d8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<HTML><HEAD>
<TITLE>Form 8-K</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>WASHINGTON, DC 20549 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>FORM 8-K
</B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>CURRENT REPORT </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Pursuant
to Section&nbsp;13 or 15(d) </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>of the Securities Exchange Act of 1934 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Date of Report (Date of earliest event reported): November&nbsp;18, 2013 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman" ALIGN="center"><B>Orthofix International N.V. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Exact name of Registrant as specified in its charter) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="34%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"><B>Cura&ccedil;ao</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>0-19961</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>N/A</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(State or other jurisdiction</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>of incorporation)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Commission</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>File Number)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(IRS Employer</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Identification No.)</B></P></TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="50%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>7 Abraham de Veerstraat</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Cura&ccedil;ao</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>N/A</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" ALIGN="center"><B>(Address of principal executive offices)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>(Zip Code)</B></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Registrant&#146;s telephone number, including area code: 011-59-99-465-8525 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the
following provisions (<I>see</I> General Instruction A.2. below): </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD>
<TD ALIGN="left" VALIGN="top">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD>
<TD ALIGN="left" VALIGN="top">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD>
<TD ALIGN="left" VALIGN="top">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD>
<TD ALIGN="left" VALIGN="top">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) </TD></TR></TABLE> <P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="12%" VALIGN="top" ALIGN="left"><B>Item&nbsp;3.01.</B></TD>
<TD ALIGN="left" VALIGN="top"><B><U>Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing</U>. </B></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As previously disclosed, on August&nbsp;16, 2013, the Company received a notification from the NASDAQ Stock Market (&#147;<U>NASDAQ</U>&#148;)
stating that the Company was no longer in compliance with NASDAQ Listing Rule 5250(c)(1) because it did not timely file with the Securities and Exchange Commission its Quarterly Report on Form 10-Q for the quarter ended June&nbsp;30, 2013. The
Company subsequently submitted to the staff of the listing qualifications department of NASDAQ (the &#147;<U>NASDAQ Staff</U>&#148;), pursuant to the NASDAQ Staff&#146;s request as set forth in the notification, a plan to regain compliance with
NASDAQ&#146;s continued listing requirements. The NASDAQ Staff has discretion to grant up to 180 calendar days (i.e., to February&nbsp;10, 2014) from the original non-compliance date for the Company to regain compliance. A 180 calendar day extension
is the maximum discretionary period the NASDAQ Staff may grant without requiring further proceedings involving a NASDAQ hearings panel. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On November&nbsp;18, 2013, the Company received a supplemental notice from NASDAQ stating that (i)&nbsp;the Company&#146;s compliance plan
remains under review by the NASDAQ Staff, and (ii)&nbsp;the Company is also out of compliance with NASDAQ Listing Rule 5250(c)(1) because it has not timely filed its Quarterly Report on Form 10-Q for the quarter ended September&nbsp;30, 2013. The
supplemental notice further requests that the Company provide the NASDAQ Staff with an update to its compliance plan by December&nbsp;4, 2013. The Company intends to provide the requested update to the NASDAQ Staff by such date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On November&nbsp;22, 2013 the Company issued a press release regarding the foregoing matters. A copy of the press release is filed herewith as
Exhibit 99.1 to this Form 8-K, and incorporated herein by reference. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="12%" VALIGN="top" ALIGN="left"><B>Item&nbsp;9.01.</B></TD>
<TD ALIGN="left" VALIGN="top"><B><U>Financial Statements and Exhibits</U>. </B></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(d) Exhibits </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="94%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.1</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top">Press Release, dated November&nbsp;22, 2013</TD></TR>
</TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SIGNATURES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Orthofix International N.V. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="6%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00pt solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Jeffrey M. Schumm</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Jeffrey M. Schumm</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Chief Administrative
Officer, General Counsel and Corporate Secretary</P></TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Date: November&nbsp;22, 2013 </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXHIBIT INDEX </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD WIDTH="90%"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:37.30pt; font-size:8pt; font-family:Times New Roman">Exhibit&nbsp;No.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:37.25pt; font-size:8pt; font-family:Times New Roman">Description</P></TD></TR>


<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Press Release, dated November 22, 2013</TD></TR>
</TABLE>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>d633841dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g633841g55v75.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Orthofix Provides Update Regarding NASDAQ Listing Matters </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Lewisville, TX, November&nbsp;22, 2013 &#150; Orthofix International N.V. (NASDAQ:OFIX) (the &#147;Company&#148;) today provided an update regarding the
status of its compliance with the Listing Rules of the NASDAQ Stock Market (&#147;NASDAQ&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As previously disclosed, on August&nbsp;16, 2013, the
Company received a notification from NASDAQ stating that the Company was no longer in compliance with NASDAQ Listing Rule 5250(c)(1) because it did not timely file with the Securities and Exchange Commission its Quarterly Report on Form 10-Q for the
quarter ended June&nbsp;30, 2013. The Company subsequently submitted to the staff of the listing qualifications department of NASDAQ (the &#147;NASDAQ Staff&#148;), pursuant to the NASDAQ Staff&#146;s request as set forth in the notification, a plan
to regain compliance with NASDAQ&#146;s continued listing requirements. The NASDAQ Staff has discretion to grant up to 180 calendar days (i.e., to February&nbsp;10, 2014) from the original non-compliance date for the Company to regain compliance. A
180 calendar day extension is the maximum discretionary period the NASDAQ Staff may grant without requiring further proceedings involving a NASDAQ hearings panel. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On November&nbsp;18, 2013, the Company received a supplemental notice from NASDAQ stating that (i)&nbsp;the Company&#146;s compliance plan remains under
review by the NASDAQ Staff, and (ii)&nbsp;the Company is also out of compliance with NASDAQ Listing Rule 5250(c)(1) because it has not timely filed its Quarterly Report on Form 10-Q for the quarter ended September&nbsp;30, 2013. The supplemental
notice further requests that the Company provide the NASDAQ Staff with an update to its compliance plan by December&nbsp;4, 2013. The Company intends to provide the requested update to the NASDAQ Staff by such date. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>About Orthofix: </U></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Orthofix International N.V. is a
diversified, global medical device company focused on developing and delivering innovative orthopedic solutions that drive value for patients, surgeons, and providers. Orthofix&#146;s products are widely distributed around the world to surgeons and
patients via Orthofix&#146;s sales representatives and its subsidiaries, and via collaborations with other leading orthopedic product companies. In addition, Orthofix is collaborating on R&amp;D activities with leading research and clinical
organizations such as the Musculoskeletal Transplant Foundation and Texas Scottish Rite Hospital for Children. For more information about Orthofix, please visit www.orthofix.com. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Forward-Looking Statements: </U></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This communication
contains certain forward-looking statements under the Private Securities Litigation Reform Act of 1995. These forward-looking statements, which may include, but are not limited to, statements concerning the projections, financial condition, results
of operations and businesses of Orthofix and its subsidiaries and are based on management&#146;s current expectations and estimates and involve risks and uncertainties that could cause actual results or outcomes to differ materially from those
contemplated by the forward-looking statements. </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The forward-looking statements in this release do not constitute guarantees or promises of future performance.
Factors that could cause or contribute to such differences may include, but are not limited to, risks relating to the uncertain results and timing of our audit committee&#146;s review of certain accounting matters, our inability to timely file our
quarterly report on Form 10-Q for the fiscal quarters ended June&nbsp;30, 2013 and September&nbsp;30, 2013 (including our filing of a Form 12b-25 (Notification of Late Filing) with the SEC with respect to such fiscal quarters), and our intent to
file restated financial statements for certain periods, as well how these matters may impact our expenses, liquidity, legal liability, borrowing ability, product sales, relationships with customers, suppliers, strategic partners and third party
reimbursement providers, ongoing compliance obligations under our corporate integrity agreement with the Office of Inspector General of the Department of Health and Human Services, deferred prosecution agreement with the U.S. Department of Justice
and consent decree with the SEC, ability to remain in compliance with covenants and other obligations under our senior secured credit agreement, the cost and nature of our insurance coverage, continued listing of our securities on the Nasdaq Stock
Market, and other factors described in our annual report on Form 10-K for the fiscal year ended December&nbsp;31, 2012 and other subsequent periodic reports filed by the Company with the SEC. Existing and prospective investors are cautioned not to
place undue reliance on these forward-looking statements, which speak only as of the date hereof. The Company undertakes no obligation to update or revise the information contained in this press release. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Contact: </U></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Mark Quick </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Director of Investor Relations and BioStim Finance </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">markquick@orthofix.com </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">214-937-2924 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Source</U></B>: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Orthofix International N.V. </P>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g633841g55v75.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g633841g55v75.jpg
M_]C_X``02D9)1@`!`0$`8`!@``#_VP!#``H'!P@'!@H("`@+"@H+#A@0#@T-
M#AT5%A$8(Q\E)"(?(B$F*S<O)BDT*2$B,$$Q-#D[/CX^)2Y$24,\2#<]/CO_
MVP!#`0H+"PX-#AP0$!P[*"(H.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[
M.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SO_P``1"`!!`9<#`2(``A$!`Q$!_\0`
M'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`M1```@$#`P($`P4%
M!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T?`D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$!
M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$"
M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#V:HY[B&UA
M:>XE2*)!EG=L`?C3VR5.T@'L2,UA:CX1L=98-JEQ=W1'13*51?HHP*J*BW[S
M)DY)>ZCG/$'Q0@AW6^AQ"=^GVB080?0=3^E>>7^K:CJDS2WUY-.S'.&;Y1]!
MT%>B:C\+]-N8G?1[YXI%)&V1A(F1V)ZC]:\]U72+[1+TVE_`8I!R#U5QZ@]Q
M7L8;V&T-_/<\7%>WWJ;>6Q7M[FXM)/,MKB6%_P"]&Y4_I78>'OB3J-A(L.K$
MWMMG!DQ^]3W_`-K\:XJBNF=*%16DCEIU9TW>+/HBRO;;4;2.[M)EFAD&5=>]
M3UXUX#\4/H>J+:7$G^@W3!7!/$;'HP_D?_K5[+7AUZ+I2MT/>P]=5H7ZA111
M6!T!16!J?CGPOH\ACOM<M$D7K&K[V'U"YQ6,WQC\$*Q']J2''<6TG^%`'<45
MQMM\6O!-R^T:R(SZRPNH_,BNET[6--U>'SM-O[>[3N89`V/KCI0!=HHHH`**
MS]1U[2-('_$RU.TM#Z33*I/X$YK'/Q)\&`X_X2&TX]"?\*`.HHKF%^)/@QB`
M/$-ISZDC^E;6GZQIFK)OT[4+:[4=?)E5\?7'2@"[163K/BG0_#TD4>K:E#:/
M,"R"3/S`=>@K-_X65X,_Z&&U_P#'O\*`.HHKE_\`A97@S_H8;7_Q[_"C_A97
M@S_H8;7_`,>_PH`ZBBN7_P"%E>#/^AAM?_'O\*NZ5XR\.:W<O;:9JT%S*D9D
M9$SD*,9/3W%`&W17+_\`"RO!G_0PVO\`X]_A6]INIV6L6$=_I]PEQ;2YV2IT
M;!(/Z@T`6J**S-9\1Z/X>2)]7OXK-9B1&9,_,1UZ?6@#3HKG[#QYX6U.]BLK
M+6K>>XF;;'&N<L?RKH*`"BL_5->TG18]^IZE;6@/($L@4GZ#J:YNX^+O@FW?
M8=7,GO'!(P_/%`':45PZ?&+P0[!?[4D7/=K:0#^5;NE^,O#>M.(]/UJTFD/2
M/S-KG_@)P:`-NBBB@`HJ&YN[:RB,MW<16\8ZO*X4?F:PI_B%X0MV*R>(;'(_
MN2;OY9H`Z.BN7_X65X,_Z&&U_P#'O\*/^%E>#/\`H8;7_P`>_P`*`.HHK$'C
M+PZ=&.L?VM!]@$OE>?SMW^G3K5(?$KP83@>(+7_Q[_"@#J**QM6\7>']"GC@
MU34XK221-Z"0'YE]1Q52#XA^$+FXCMX=?M&DE8*@R1DG@#)%`'24444`%%<[
M>>/_``G87<MI=:[:QSPL5D3).T]QP*FTWQIX;UB=X-/U>"X>-#(X7("J.I)(
MP!0!N45GV>NZ9?SB"VNU>1@612I7>!W7(&X?3-%`$.M^)=*T"+=?7($A&5A3
MYG;Z#^IKS/Q!\0]5U?=!9DV%J>,(?WC#W;M^%<M<7$MW<R7$SEY)6+,S'))-
M1U[='"0IZO5GA5L9.IHM$>R?#9@W@Z'G)$LF?KNK6\0Z!:>(=,>SN5`?K%*!
MS&WJ/ZBN6^%%\)-*O+`D;H9A(![,/\17?5YE>\*S:WN>I0M.@D]K'SQ?V%QI
ME_-972;)H6VL.Q]Q['K5>O2?BIHR^7;ZU$N&!\F;'<=5/\Q^(KS:O9HU/:04
MCQ*]+V51Q`C->W^"-6;6/"]M-(VZ:',,A/<KW_$8KQ"O2_A+<$VVI6Q/"NC@
M?4$'^0K#&PO2OV.C`S:JV[GH9(4%F(`'))[5\[_$3XH:AX@OY].TFY>VTF-B
M@,1*M<8_B8^GH/SKV;X@WLFG^`M9N8F*N+8H".HW87^M?*U>*>X;/AGPGJ_B
MV_-II5N'V#,DKG:D8]6/].M>E6O[/TAB!O/$"K)W$5OD#\2PKMOA/I,&E_#_
M`$]XT`EO%-Q*W=BQX_(8%=G0!X%KGP+UNPMGN-+O8=2V#/D[3'(1[9)!/XBO
M.K.]U#1;\3VD\]G=0MC<A*,I'4'_``-?85?.WQLTJ'3_`!S]IA0(+ZW69P.[
MY*D_C@4`>F_"_P"(!\8Z=):W^U=4M`#(5&!*G0.!VYX(^GK6'\7?B->:)./#
M^BS>3<L@>YN%^]&#T5?0D<D_2O/OA)>R67Q&TX(<+<;X7'J"I/\`,"LWX@7+
M7?CW6I6)/^EN@SZ*=H_E0!DVEIJ.NZDMO;1S7MY<-PHRSN?4G^IKT"R^!/B:
MXB#W5W86A/\``SL[#ZX&/UJ#X5>+O#7A#[==:NLYO)RJ1-'%OVQCD\YXR<?D
M*]&_X7=X._OWW_@/_P#7H`\\O_@;XIM(&EMYK&\*@GRXY&5C]-P`_6N!MKJ]
MTF_$]K-+:74#<,C%64@U[IJ/QV\.P6[G3[.]NI\?(KH(US[G.<?A7@]S.]Y=
MRW#@;YI&=@/4G-`'KT^@ZI\8_#ND:PE[;6US9K);W(D4_.X(.X8'<8/XU1_X
M4#K?_08L/^^7_P`*]"^$NAW6A>!;>.]0QS7,C7!C88*!L``^^`#^-=K0!\I^
M,_!]UX+U2+3[NYAN'EA$H:('`&2,<_2H/"GAJX\6:]%I%M/'!)(C,'D!VC:,
M]J[7X\_\CA9_]>2_^AM69\&/^2CVG_7&7_T`T`;7_"@=;_Z#%A_WR_\`A72^
M!OA=J/@S5;O4[O4+6XC>RDA"1!LY)4YY'^S7J50WG_'E/_US;^5`'QRWWC]:
M^FOA)_R332?I+_Z->OF5OO'ZUZIX-^,-EX7\*V>C2Z1/</;!\R+*`&RY;ICW
MH`]XKR']H'_D&Z+_`-=I?Y+3O^&@-/\`^@!<_P#?]?\`"N+^(_Q%MO'-K8PP
M:=+:&U=V)>0-NR`.P]J`,OX9_P#)1=%_Z^/_`&4UZW\5OB--X7B32-(91J5P
MF]Y2,^0AX!`_O'MZ5Y)\,_\`DHNB_P#7Q_[*:A^(5])J'CW69I"25NFC7/8)
M\H'Y"@#'9M0UK41N:>]O+EPHR2[NQ[>]>E:-\!]7N[=)M5U*"Q9AGR43S67Z
MG(&?IFD^`^DP77B&_P!3F0,]E"JQ9_A9R<GZX!'XU[S0!XI>?L_SK&38Z_&[
M@<+-`5!_$$_RKS+Q!X<U7PMJ9L=4MS#*!N1@<JX]5/<5]<5YW\;=*AO?`K7K
M(#-8S(Z/W`8[6'ZC\A0!Q7PP^*%[8:C;Z'KERUQ8SL(X9I3EH&/`!/=<\<]*
M]9\;>*8O"'AJ?5'022Y$<$9/#R'H#[=2?85\I@D$$'!'>O5/BYK$NH>%O"0<
MG-S:?:9.>K%$']3^=`'GFM:]JOB*^:[U2\EN96/`8_*OLHZ`?2NNT/X,^*=7
MMDN9EM].BD&5%RQWD?[H!Q^.*Y7POJ%AI7B6QU#4X)+BUMI1(\<8!+$<C@D#
MKBO9_P#A??AO_H&:I_WQ'_\`%T`<V/@!JV!G6[,'VC:E_P"%`:K_`-!RS_[]
M-71_\+[\-_\`0,U3_OB/_P"+K;\)?%'2/&.L'3+&SO891$TNZ=4"X!`[,?6@
M#B_%WA6?P=\&GTJXN8[E_P"TEEWQJ0,$=.?I7CT/^N3_`'A_.OHCXW?\D^;_
M`*^XOZU\[P_ZY/\`>'\Z`/JKQ-X3T_QAX=&GWJA7"!H)P,M"^.H]O4=Z^9O$
M7A_4/#&L3:9J,6R6,_*P^[(O9E/<&OK6#_CWC_W!_*N>\<>"K'QIHYMI\17<
M0+6UP!S&WH?53W%`'%?"7XE?VBD7AS6Y_P#2T&VTN'/^M`_@)_O#MZ_7K=^*
MWQ)&@6[Z'H\P.IS+B:53_P`>RG_V8_IU]*\/U72M1\.:Q+8WL;VUY;..A_$,
MI].X-100WVMZJD,?F75[>2X&YLM(['N30!+HVCZAXBU>'3M/A:>YG;\`.[,>
MP'4FOH73?`]IX1\(K:6L)NY/.BFOV5<M<*K`L`.X`SA>^,=35KX?>`[7P7I6
M&VS:E<`&YGQ_XXO^R/UZUUU`'CUKIE]=1W4%G<K=WUU'OM3;R_Z@^<[,9#GY
M3Y9`!..&*XHKV`*JDD``GDX'6B@#YZU*U-CJEW:$8,$SI^1JM79?$S2#8^(1
M?HN(;Y<D]@XX/Z8-<;7T5*?/!2/F:T.2HXF]X,UP:#XBAGE;%O-^ZF]E/0_@
M<&O<`0P!!!!Y!'>OG&O2OA_XT1HH]$U27:Z_+;3.>&'9"?7TKCQE!R]^)W8'
M$*/[N7R.M\660O\`PMJ,!&3Y#.OU7YA_*O"!R*^A]0Q_9USN^[Y+Y_(U\\#H
M*6`?NR0\Q7O185Z1\)(FV:G-_#F-1]>37F]>T^`-(?2?"\/FKMFN29W!ZC/0
M?D!6N-DE2MW,<#!NM?L2^/K"34_`FL6D2EI&MF95'<K\V/TKY4K[+(!&#R*\
M!^(WPIO])OI]5T*V>YTZ5B[0Q#+VY/)&.Z^A'3O7BGNGI7PDUB#5?`-C%&X,
MUB#;RIGE2#\OYJ17:U\E>'O$VL>$]1-WI=RT$A^62-AE)!Z,O?\`G7HEM\?]
M12("ZT*VE<=6CF9`?P(-`'N-?.7QHUF'5?'+06[ATL(5@9ATWY)8?AG'U!JQ
MKOQM\1ZK;/;6,,&F(X(+Q$M)CV8]/P&:X;3-(U37[X6VG6<]Y<.<D(I/XD]O
MJ:`.G^$5A)??$73V0';;!YG/H`I'\R*Q/&?_`".NM?\`7]-_Z&:]\^&O@!?!
M>F22W3)+J=V!YS+RL:CH@/\`,]S]*\"\8L'\9ZTR]/M\W_H9H`ZCX=?#2U\;
MZ7=WD^I36K6\_E!4C#`C:#GD^]=;)^S_`&/E-Y6O7'F8.W=`N,]L\]*L?`+_
M`)%K4_\`K\'_`*`*]6H`^/\`5])O-#U2XTW4(C%<6[[77L?0CU!Z@UZM\%[7
MPAJ(*SZ?&==M?G#3L7#KGAD4\`CH?P-=7\4_`"^*]+_M"PB']K6B'9C_`);I
MU*'W]/R[U\^Z=J%[HFJ0WUG(]O=VS[E.,%2.H(_0B@#[!HKF_`_C&T\9Z$E[
M#MCNH\)<P9YC?V]CU!_PKI*`/`?CS_R.%G_UY+_Z&U9GP8_Y*/:?]<9?_0#6
MG\>?^1PL_P#KR7_T-JS/@Q_R4>T_ZXR_^@&@#Z1J&\_X\I_^N;?RJ:H;S_CR
MG_ZYM_*@#XY;[Q^M>S^`OA7X;\1^#+#5K\7?VFX#[_+FVKP[*,#'H!7C#?>/
MUKZ:^$G_`"332?I+_P"C7H`SO^%(>#_2_P#_``('^%<!\5O`>B^#K/3I=*^T
M;KF1U?S9-W``QCCWKZ"KR']H'_D&Z+_UVE_DM`'G/PS_`.2BZ+_U\?\`LIJ/
MXBV$FG>/M8A=2-]RTJY[J_S`_K4GPS_Y*+HO_7Q_[*:]A^*/PY;Q=;IJ6F;5
MU2V3;M8X$Z==N>Q'.#[XH`X?X$:Q!9^)+W3)G"-?0@Q9[LA)Q^1/Y5[W7Q_<
MVFIZ#J02XAN+&\@8,NX%'4CH1_B*]!T?XZZ_8VZ0ZC9VVH[1CS23&Y^I'!_*
M@#W^O./C?K$%EX+&FF0?:+^90J=]JG<3],@#\:Y*\^/VJ21%;/1;6!R.'DE:
M3'X<5YSK&MZKXGU0WFHW$EW<R?*H`Z#LJJ.@]A0!FJI9@J@DDX`'>O2OB]9/
MIMAX3L9,[[?3?+;/J`H-:/PQ^%5Z^HP:[X@MS;V\!$D%K(,/(PZ%AV`ZX/)^
ME+^T!_R%=&_ZX2?^A"@#@O`VA6OB3Q?8Z3>O(D%P7W&(@,,*3QD'TKV'_A1'
MA?\`Y_-2_P"_J?\`Q->8?";_`)*3I7UD_P#1;5]-T`>9_P#"B/"__/YJ7_?U
M/_B:VO"OPQT7PAJYU/3[B\DF,318F=2N"0>P'I7944`>>_&[_DGS?]?<7]:^
M=X?]<G^\/YU]$?&[_DGS?]?<7]:^=X?]<G^\/YT`?8T'_'O'_N#^5<MX^\>V
M7@K3,G;/J,ZG[/;Y_P#'F]%'Z]*7QGXXL?!>@I-*5EOIH\6UMGESCJ?11W/X
M5\VZIJFH>(-6EOKZ5[F[N&Y.,_10/3L!0`MQ<:IXFULRR&6]O[V3``Y9F/0`
M>G\J75](U/PSK#V-_$]M=VY#`JWXAE(Z_45[K\+/APOAFT75]5B!U6=?E0C/
MV93V_P!X]S^'KG6^(W@2#QGH^80L>IVP)MI3QN]48^A_0_C0!D?"[XE)XEME
MT?5I0NJPK\DC''VE1W_WAW'?KZUZ17QXRWNCZF582VEY:2_[KQNI_GFOH?X:
M_$6#Q?8BROG2+5X%^=.@F4?QK_4=OI0!WE%%%`&1XGT*+Q#HLMDV%E^_"Y_A
M<=/P[?C7AEU:SV5U):W,9CFB8JZ'L:^BJYOQ7X,L_$L8F#"WO4&%F`R&'HP[
MC^5=N%Q'L_=EL<.+PWM5S1W/%*N:9I-_K-R+?3[5YW[[1PON3T%=WHGPL*R^
M;K=RK*IXA@)PWU;^@KT"RL+33K9;>RMXX(EZ*BX'_P!>NNKC81TAJSCHX&<M
M9Z(Y29=4\->`+T:OJ"W4WD^7%@<IN&T+NZMU_2O(^@KU+Q9!J?C&_CTG28_]
M!M7S/=/Q&9.F`?XL<].]:OA[P%I.B;9I4^V78Y\V4<*?]E>@_G6=.M&C!N7Q
M/H:U:$JTU&/PKJ<9X+\#W.I7D=_J=NT-C&0ZI(,&8]N/[O\`.O6NE+17#6K2
MJRNSNHT(T8V04445B;F1J?A3P_K#%]1T>SN'/5WB&[\^M8[?"GP.[%CH,8)]
M)I0/T:NOHH`Y6W^&7@NU8-'X?MF(_P">A:3_`-")KH[2QM-/A$-G:PVT8_@B
M0*/R%3T4`%84_@CPM<SR3S^'["265B[NT"DLQ.23^-;M%`%'2]%TS187ATNP
M@LXY&W.L*!0QZ9.*O444`%8=SX+\,7ES)<W.@V$LTK%GD:!26)ZDUN44`9>F
M>&M$T6=I]+TJULY'7:S0QA21Z'%:E%%`&7J?AG0M9N%N-3TFTO)578KS1!B!
MUQD_6F:?X3\/:3=K=Z?HUG:W"@A98H0K`'@\UKT4`%(RAU*L`01@@]Z6B@#G
M_P#A`O"/_0N:=_X#K6Q86%GI=FEG86T=M;QYV11+M5<G)P/J35BB@`JAJFAZ
M5K:1IJFGV]XL1)031AMI/7&:OT4`8MGX.\-:?=QW=GH=C!/$<I)'"`RGV-;5
M%%`%6_TRPU2'R=0LH+J/^[-&''ZUST_PP\%7#;GT"W4_],V=!^2D5U=%`'(I
M\*O!$;;AH,1/^U-(1^1:MO3/#>B:,<Z;I-I:M_>CB`;\^M:=%`!6;JGAW1M;
M>-]4TRUO&B!"&:,,5!ZXS6E10!C6/A#PYIEY'>6.B65O<1YV2QPA67(P<'Z&
MMFBB@`HHHH`J:CI=AJ]K]EU&SANX-P;RYD#+D=#@UE#P%X1!R/#FG?\`@.M=
M!10!D:AX3\/:K<_:M0T:SNIMH7S)8@QP.@YJ.T\&>&;&ZCNK70;"&>)MR2)`
MH*GU!K;HH`****`,>_\`"7AW5+MKN_T6RN;A\;I9(5+-C@9--M/!OAJPNX[N
MST.RMYXCN22.$*RGV(K:HH`****`"BBB@`J.X_X]I?\`</\`*BBFMQ/8KZ5_
MR"K;_KF*N444Y?$Q1^%!1114E!1110`4444`%%%%`!1110`4444`%%%%`!11
M10`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%
4`!1110`4444`%%%%`!1110!__]D_
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
